Concepedia

Gabrielle R. de Melo

GR

Statistics

Publications

4

Citations

324

H-Index

4

Active since

2015

Affiliations

Fundação Oswaldo Cruz(Current)

Universidade Federal do Rio de Janeiro

Instituto de Química y Fisicoquímica Biológicas

D’Or Institute for Research and Education

Bruning (Brazil)

Gabrielle R. de Melo is an author at Fundação Oswaldo Cruz specializing in infectious diseases, antiviral agents, and virology.

Publications per year

2015–2023

4

Publications

4

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication

Carolina Q. Sacramento, Gabrielle R. de Melo, Caroline S. de Freitas et al. · Scientific Reports · 2017 · 241 citations · Full text

, , +15

Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin

Carolina Q. Sacramento, Andressa Marttorelli, Natalia Fintelman‐Rodrigues et al. · PLoS ONE · 2015 · 34 citations · Full text

, , +17

The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replication

Caroline Q. Sacramento, Gabrielle R. de Melo, Natasha Rocha et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2016 · 25 citations · Full text

, , +17

Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages

André C. Ferreira, Carolina Q. Sacramento, Filipe S. Pereira‐Dutra et al. · Frontiers in Cellular and Infection Microbiology · 2023 · 24 citations · Full text

, , +17

1–4 of 4